AKT1 and melanoma: Preclinical studies treating melanoma cells in vitro with MK-2206 resulted in a concentration-dependent downregulation of phosphorylated Akt, inhibition of cell growth and colony formation, and induced apoptosis through altered expression of Bax, and increased ROS generation (Quast et al., 2013; Petit et al., 2019).